SG Americas Securities LLC Buys New Position in Healthpeak Properties, Inc. (NYSE:DOC)

SG Americas Securities LLC purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,996 shares of the real estate investment trust's stock, valued at approximately $526,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Douglas Lane & Associates LLC lifted its position in shares of Healthpeak Properties by 8.5% during the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock valued at $56,471,000 after purchasing an additional 218,395 shares in the last quarter. Ibex Wealth Advisors purchased a new stake in Healthpeak Properties in the 1st quarter valued at about $5,056,000. Vert Asset Management LLC lifted its position in shares of Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after buying an additional 20,924 shares in the last quarter. Two Sigma Advisers LP purchased a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $5,691,000. Finally, Wellington Management Group LLP grew its holdings in shares of Healthpeak Properties by 122.8% in the fourth quarter. Wellington Management Group LLP now owns 155,777 shares of the real estate investment trust's stock valued at $3,158,000 after acquiring an additional 85,867 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Healthpeak Properties

In other news, Director John T. Thomas purchased 4,200 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was purchased at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the transaction, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This trade represents a 0.52% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Tommy G. Thompson acquired 5,700 shares of the stock in a transaction that occurred on Friday, May 9th. The stock was acquired at an average price of $17.36 per share, for a total transaction of $98,952.00. Following the transaction, the director now directly owns 138,513 shares of the company's stock, valued at $2,404,585.68. This represents a 4.29% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 29,764 shares of company stock valued at $521,909. 0.23% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on DOC shares. Wedbush cut their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Saturday. Argus restated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Finally, Evercore ISI dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $23.27.

Healthpeak Properties Stock Performance

DOC stock traded up $0.40 during midday trading on Monday, reaching $17.50. 6,248,159 shares of the company's stock traded hands, compared to its average volume of 5,206,902. The firm has a market capitalization of $12.16 billion, a PE ratio of 43.75, a price-to-earnings-growth ratio of 1.95 and a beta of 1.05. The company has a 50-day moving average price of $17.60 and a two-hundred day moving average price of $19.24. Healthpeak Properties, Inc. has a 52 week low of $16.64 and a 52 week high of $23.26. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The firm's quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 earnings per share. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were given a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio is presently 305.00%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.